Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.

@article{Kochhaeuser2017RiskOS,
  title={Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.},
  author={Simon Kochhaeuser and Pouria Alipour and Tanjah Haig-Carter and Kathleen Trought and Philip Hache and Yaariv Khaykin and Zaev A. Wulffhart and Alfredo Pantano and Bernice Tsang and David Hugh Birnie and Atul Verma},
  journal={Journal of cardiovascular electrophysiology},
  year={2017},
  volume={28 3},
  pages={273-279}
}
INTRODUCTION Because of the unclear prognostic effects of ablation of atrial fibrillation (AF), oral anticoagulation (OAC) is often continued after ablation even in asymptomatic patients. We sought to determine the frequency of stroke and AF recurrence in patients on and off therapeutic OAC 1 year after a successful AF ablation. METHODS AND RESULTS Patients that underwent AF ablation and were free of AF 12 months after ablation were selected from our AF database. During follow-up (FU… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
During follow - up ( FU ) , patients were screened for recurrence of AF , changes in OAC or antiarrhythmic medication , and the occurrence of stroke or transient ischemic attack ( TIA ) .
There was a trend toward a higher percentage of coronary artery disease among patients that experienced stroke ( 50% vs. 10% ; P = 0.057 ) .
There was a trend toward a higher percentage of coronary artery disease among patients that experienced stroke ( 50% vs. 10% ; P = 0.057 ) .
All Topics